7Baggers
 lynx1 capital management lp increases stake in passage bio inc  GuruFocus Thu, 18 Sep 2025 01:19:12 GMT
 lynx1 capital buys passage bio (pasg) shares worth $223,734  Investing.com Tue, 16 Sep 2025 00:51:03 GMT
 Lynx1 Capital buys Passage Bio (PASG) shares worth $223,734  Investing.com Mon, 15 Sep 2025 07:00:00 GMT
 passage bio (pasg) stock price, news & analysis  MarketBeat Fri, 05 Sep 2025 07:00:00 GMT
 published on: 2025-08-29 12:06:33  Newser Fri, 29 Aug 2025 17:06:33 GMT
 published on: 2025-08-29 00:11:05  Newser Fri, 29 Aug 2025 05:11:05 GMT
 published on: 2025-08-28 16:23:02  Newser Thu, 28 Aug 2025 21:23:02 GMT

Passage Bio, Inc
(NASDAQ:PASG) 

PASG stock logo

Passage Bio, Inc., a genetic medicines company, develops transformative therapies for rare monogenic central nervous system (CNS) diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid b...

Founded: 2017
Full Time Employees: 20
CEO: Bruce A. Goldsmith  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends